Vertex Pharma (VRTX)
404.91
0.00 (0.00%)
Upcoming Events
Latest Headlines
VERTEX AND TREEFROG THERAPEUTICS ANNOUNCE LICENSING AGREEMENT AND COLLABORATION TO OPTIMIZE PRODUCTION OF VERTEX'S CELL THERAPIES FOR TYPE 1 DIABETES
April 23, 2024 12:45 AM - PR NewsWire
Vertex Pharma (VRTX) Announces Advancements of Suzetrigine (VX-548) in Acute and Neuropathic Pain
April 18, 2024 8:03 AM - StreetInsider
Vertex Announces Advancements of Suzetrigine (VX-548) in Acute and Neuropathic Pain
April 18, 2024 8:00 AM - BizWire
Form 4 VERTEX PHARMACEUTICALS For: Apr 15 Filed by: SACHS BRUCE I
April 17, 2024 4:08 PM - SEC Filing
Vertex (VRTX) PT Lowered to $466 at UBS
April 17, 2024 8:14 AM - StreetInsider
Form PX14A6G VERTEX PHARMACEUTICALS Filed by: Arjuna Capital
April 16, 2024 4:57 PM - SEC Filing
Vertex (VRTX) PT Raised to $450 at Guggenheim
April 16, 2024 1:15 PM - StreetInsider
Vortex Energy Corp. Sends Core Samples from the Robinsons River Salt Project to the University of Alberta
April 16, 2024 8:02 AM - Globe NewsWire
Truist Securities Assumes Vertex (VRTX) at Buy
April 15, 2024 4:48 PM - StreetInsider
Nike, Alpine Immune Sciences rise premarket; CarMax, Robinhood and Regeneron fall
April 11, 2024 8:12 AM - StreetInsider
Form SC TO-C VERTEX PHARMACEUTICALS Filed by: VERTEX PHARMACEUTICALS INC / MA
April 11, 2024 7:18 AM - SEC Filing
Form 8-K VERTEX PHARMACEUTICALS For: Apr 10
April 11, 2024 7:14 AM - SEC Filing
Evercore ISI Upgrades Vertex (VRTX) to Outperform
April 11, 2024 6:01 AM - StreetInsider
Vertex Pharma (VRTX) April 430 and 440 puts active
April 11, 2024 4:39 AM - StreetInsider
US stock futures fall after hot inflation dashes rate cut hopes
April 11, 2024 3:45 AM - StreetInsider
After-hours movers: Alpine Immune Sciences, Costco, and more
April 10, 2024 4:57 PM - StreetInsider
Vertex Pharma bets on kidney disease treatment with $4.9 billion Alpine Immune deal
April 10, 2024 4:19 PM - StreetInsider
Vertex (VRTX) Enters Into Agreement to Acquire Alpine Immune Sciences (ALPN)
April 10, 2024 4:02 PM - StreetInsider
Vertex Enters Into Agreement to Acquire Alpine Immune Sciences
April 10, 2024 4:01 PM - BizWire
Form SC 13G/A VERTEX PHARMACEUTICALS Filed by: Capital World Investors
April 10, 2024 12:14 PM - SEC Filing
Vertex to Announce First Quarter 2024 Financial Results on May 6
April 9, 2024 4:05 PM - BizWire
Vortex Energy Announces Drilling Update and $115,500 Grant Award At The Robinsons River Salt Project
April 9, 2024 8:00 AM - Globe NewsWire
Truist Breaks Down The 'uptake and total addressable market of VRTX's NAV 1.8 pain drug VX-548'
April 5, 2024 1:46 PM - StreetInsider
Form ARS VERTEX PHARMACEUTICALS For: Dec 31
April 4, 2024 4:06 PM - SEC Filing
Form DEFA14A VERTEX PHARMACEUTICALS
April 4, 2024 4:04 PM - SEC Filing
Form DEF 14A VERTEX PHARMACEUTICALS For: May 15
April 4, 2024 4:02 PM - SEC Filing
Form 4 VERTEX PHARMACEUTICALS For: Apr 01 Filed by: Ambrose Kristen
April 3, 2024 4:02 PM - SEC Filing
Vertex Pharma (VRTX) Reports NDA for exagamglogene autotemcel Accepted for Priority Review in Canada
April 1, 2024 11:03 AM - StreetInsider
Vertex Pharma (VRTX) Advances Inaxaplin into Phase 3 Portion of Adaptive Phase 2/3 Trial
April 1, 2024 8:09 AM - StreetInsider
Vertex Advances Inaxaplin (VX-147) into Phase 3 Portion of Adaptive Phase 2/3 Clinical Trial for the Treatment of APOL1-Mediated Kidney Disease
April 1, 2024 8:00 AM - BizWire
Vortex Energy Closes Charity Flow-Through Private Placement for Gross Proceeds of C$830,000
March 26, 2024 8:00 AM - Globe NewsWire
Vertex Pharma (VRTX) Announces FDA Clearance of Investigational New Drug Application for VX-407 for the Treatment of Autosomal Dominant Polycystic Kidney Disease
March 21, 2024 8:00 AM - StreetInsider
Vertex Announces FDA Clearance of Investigational New Drug Application for VX-407 for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
March 21, 2024 8:00 AM - BizWire
Form 4 VERTEX PHARMACEUTICALS For: Feb 23 Filed by: WAGNER CHARLES F JR
February 27, 2024 5:10 PM - SEC Filing
Form 4 VERTEX PHARMACEUTICALS For: Feb 23 Filed by: Tatsis Ourania
February 27, 2024 5:05 PM - SEC Filing
Form 4 VERTEX PHARMACEUTICALS For: Feb 23 Filed by: Sachdev Amit
February 27, 2024 5:01 PM - SEC Filing
Form 4 VERTEX PHARMACEUTICALS For: Feb 23 Filed by: Kewalramani Reshma
February 27, 2024 4:57 PM - SEC Filing
Form 4 VERTEX PHARMACEUTICALS For: Feb 23 Filed by: Bozic Carmen
February 27, 2024 4:52 PM - SEC Filing
Form 4 VERTEX PHARMACEUTICALS For: Feb 23 Filed by: Atkinson Edward Morrow III
February 27, 2024 4:46 PM - SEC Filing
Form 4 VERTEX PHARMACEUTICALS For: Feb 23 Filed by: Arbuckle Stuart A
February 27, 2024 4:39 PM - SEC Filing
Form 4 VERTEX PHARMACEUTICALS For: Feb 23 Filed by: Ambrose Kristen
February 27, 2024 4:32 PM - SEC Filing
Form 4 VERTEX PHARMACEUTICALS For: Feb 23 Filed by: ALTSHULER DAVID
February 27, 2024 4:27 PM - SEC Filing
Form 144 VERTEX PHARMACEUTICALS Filed by: Arbuckle Stuart A
February 26, 2024 1:19 PM - SEC Filing
Form 144 VERTEX PHARMACEUTICALS Filed by: ALTSHULER DAVID
February 26, 2024 11:25 AM - SEC Filing
Form 144 VERTEX PHARMACEUTICALS Filed by: Tatsis Ourania
February 26, 2024 11:13 AM - SEC Filing
Form 144 VERTEX PHARMACEUTICALS Filed by: Sachdev Amit
February 26, 2024 10:53 AM - SEC Filing
Form 144 VERTEX PHARMACEUTICALS Filed by: Atkinson Edward Morrow III
February 26, 2024 10:44 AM - SEC Filing
Form 144 VERTEX PHARMACEUTICALS Filed by: Sanna Bastiano
February 26, 2024 10:27 AM - SEC Filing
Form 4 VERTEX PHARMACEUTICALS For: Feb 21 Filed by: Tatsis Ourania
February 23, 2024 4:32 PM - SEC Filing
Form 4 VERTEX PHARMACEUTICALS For: Feb 21 Filed by: Sachdev Amit
February 23, 2024 4:27 PM - SEC Filing
Form 4 VERTEX PHARMACEUTICALS For: Feb 21 Filed by: Atkinson Edward Morrow III
February 23, 2024 4:19 PM - SEC Filing
Form 4 VERTEX PHARMACEUTICALS For: Feb 21 Filed by: Arbuckle Stuart A
February 23, 2024 4:13 PM - SEC Filing
Form 4 VERTEX PHARMACEUTICALS For: Feb 21 Filed by: ALTSHULER DAVID
February 23, 2024 4:11 PM - SEC Filing
Vertex Pharma (VRTX) Receives CHMP Positive Opinion for KALYDECO
February 23, 2024 7:12 AM - StreetInsider
Vertex Receives CHMP Positive Opinion for KALYDECO® for the Treatment of Infants With Cystic Fibrosis Ages 1 Month and Older
February 23, 2024 7:10 AM - BizWire
Form 4 VERTEX PHARMACEUTICALS For: Feb 16 Filed by: WAGNER CHARLES F JR
February 21, 2024 4:51 PM - SEC Filing
Form 4 VERTEX PHARMACEUTICALS For: Feb 16 Filed by: Tatsis Ourania
February 21, 2024 4:47 PM - SEC Filing
Form 4 VERTEX PHARMACEUTICALS For: Feb 16 Filed by: Sachdev Amit
February 21, 2024 4:40 PM - SEC Filing
Form 4 VERTEX PHARMACEUTICALS For: Feb 20 Filed by: LEIDEN JEFFREY M
February 21, 2024 4:36 PM - SEC Filing
Form 4 VERTEX PHARMACEUTICALS For: Feb 16 Filed by: Kewalramani Reshma
February 21, 2024 4:33 PM - SEC Filing
Form 4 VERTEX PHARMACEUTICALS For: Feb 16 Filed by: Bozic Carmen
February 21, 2024 4:28 PM - SEC Filing
Form 4 VERTEX PHARMACEUTICALS For: Feb 16 Filed by: Atkinson Edward Morrow III
February 21, 2024 4:26 PM - SEC Filing
Form 4 VERTEX PHARMACEUTICALS For: Feb 16 Filed by: Arbuckle Stuart A
February 21, 2024 4:20 PM - SEC Filing
Form 4 VERTEX PHARMACEUTICALS For: Feb 16 Filed by: ALTSHULER DAVID
February 21, 2024 4:15 PM - SEC Filing
Form 144 VERTEX PHARMACEUTICALS Filed by: Arbuckle Stuart A
February 21, 2024 11:38 AM - SEC Filing
Form 144 VERTEX PHARMACEUTICALS Filed by: Atkinson Edward Morrow III
February 21, 2024 10:53 AM - SEC Filing
Form 144 VERTEX PHARMACEUTICALS Filed by: Tatsis Ourania
February 21, 2024 10:45 AM - SEC Filing
Form 144 VERTEX PHARMACEUTICALS Filed by: ALTSHULER DAVID
February 21, 2024 10:16 AM - SEC Filing
Form 144 VERTEX PHARMACEUTICALS Filed by: Sanna Bastiano
February 21, 2024 9:51 AM - SEC Filing
Form 144 VERTEX PHARMACEUTICALS Filed by: Sachdev Amit
February 21, 2024 9:44 AM - SEC Filing
Vertex to Participate in Upcoming Investor Conferences
February 20, 2024 4:05 PM - BizWire
Form 144 VERTEX PHARMACEUTICALS Filed by: Arbuckle Stuart A
February 20, 2024 11:30 AM - SEC Filing
Form 144 VERTEX PHARMACEUTICALS Filed by: Tatsis Ourania
February 20, 2024 11:04 AM - SEC Filing
Form 144 VERTEX PHARMACEUTICALS Filed by: ALTSHULER DAVID
February 20, 2024 10:57 AM - SEC Filing
Form 144 VERTEX PHARMACEUTICALS Filed by: Sanna Bastiano
February 20, 2024 10:32 AM - SEC Filing
Form 144 VERTEX PHARMACEUTICALS Filed by: Sachdev Amit
February 20, 2024 10:23 AM - SEC Filing
Form 144 VERTEX PHARMACEUTICALS Filed by: Atkinson Edward Morrow III
February 20, 2024 10:23 AM - SEC Filing
Form 4 VERTEX PHARMACEUTICALS For: Feb 14 Filed by: LEIDEN JEFFREY M
February 16, 2024 4:07 PM - SEC Filing
Form 10-K VERTEX PHARMACEUTICALS For: Dec 31
February 15, 2024 4:15 PM - SEC Filing
Wolfe Research begins coverage on biotech, names Alpine Immune Sciences as Top Pick
February 15, 2024 3:43 PM - StreetInsider
Form 144 VERTEX PHARMACEUTICALS Filed by: LEIDEN JEFFREY M
February 15, 2024 11:19 AM - SEC Filing
Form 144 VERTEX PHARMACEUTICALS Filed by: Sanna Bastiano
February 14, 2024 5:12 PM - SEC Filing
Form 144 VERTEX PHARMACEUTICALS Filed by: LEIDEN JEFFREY M
February 14, 2024 4:13 PM - SEC Filing
Wolfe Research Starts Vertex (VRTX) at Outperform
February 14, 2024 4:08 PM - StreetInsider
Form 4 VERTEX PHARMACEUTICALS For: Feb 12 Filed by: LEIDEN JEFFREY M
February 14, 2024 4:06 PM - SEC Filing
Form 4 VERTEX PHARMACEUTICALS For: Feb 09 Filed by: Tatsis Ourania
February 13, 2024 6:28 PM - SEC Filing
Form SC 13G/A VERTEX PHARMACEUTICALS Filed by: VANGUARD GROUP INC
February 13, 2024 6:21 PM - SEC Filing
Form 4 VERTEX PHARMACEUTICALS For: Feb 09 Filed by: WAGNER CHARLES F JR
February 13, 2024 5:34 PM - SEC Filing
Form 4 VERTEX PHARMACEUTICALS For: Feb 09 Filed by: Sachdev Amit
February 13, 2024 5:22 PM - SEC Filing
Form 4 VERTEX PHARMACEUTICALS For: Feb 09 Filed by: Kewalramani Reshma
February 13, 2024 5:13 PM - SEC Filing
Form 4 VERTEX PHARMACEUTICALS For: Feb 09 Filed by: Bozic Carmen
February 13, 2024 5:04 PM - SEC Filing
Form 4 VERTEX PHARMACEUTICALS For: Feb 09 Filed by: Biller Jonathan
February 13, 2024 4:58 PM - SEC Filing
Form 4 VERTEX PHARMACEUTICALS For: Feb 09 Filed by: Atkinson Edward Morrow III
February 13, 2024 4:54 PM - SEC Filing
Form 4 VERTEX PHARMACEUTICALS For: Feb 09 Filed by: Arbuckle Stuart A
February 13, 2024 4:52 PM - SEC Filing
Form 4 VERTEX PHARMACEUTICALS For: Feb 09 Filed by: Ambrose Kristen
February 13, 2024 4:49 PM - SEC Filing
Form 4 VERTEX PHARMACEUTICALS For: Feb 09 Filed by: ALTSHULER DAVID
February 13, 2024 4:46 PM - SEC Filing
Form 144 VERTEX PHARMACEUTICALS Filed by: LEIDEN JEFFREY M
February 13, 2024 3:24 PM - SEC Filing
European Commission Approves First CRISPR/Cas9 Gene-Edited Therapy, CASGEVY™ (exagamglogene autotemcel), for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia
February 13, 2024 1:59 AM - BizWire
Form 144 VERTEX PHARMACEUTICALS Filed by: LEIDEN JEFFREY M
February 12, 2024 4:23 PM - SEC Filing
Form 4 VERTEX PHARMACEUTICALS For: Feb 08 Filed by: LEIDEN JEFFREY M
February 12, 2024 4:09 PM - SEC Filing
Form 144 VERTEX PHARMACEUTICALS Filed by: Biller Jonathan
February 12, 2024 1:42 PM - SEC Filing
Form 144 VERTEX PHARMACEUTICALS Filed by: Atkinson Edward Morrow III
February 12, 2024 1:25 PM - SEC Filing
Form 144 VERTEX PHARMACEUTICALS Filed by: Arbuckle Stuart A
February 12, 2024 12:45 PM - SEC Filing
Form 144 VERTEX PHARMACEUTICALS Filed by: Tatsis Ourania
February 12, 2024 11:33 AM - SEC Filing
Form 144 VERTEX PHARMACEUTICALS Filed by: ALTSHULER DAVID
February 12, 2024 10:33 AM - SEC Filing
Form 144 VERTEX PHARMACEUTICALS Filed by: Sachdev Amit
February 12, 2024 9:52 AM - SEC Filing
Vertex (VRTX) PT Raised to $465 at Argus
February 12, 2024 8:08 AM - StreetInsider
Form SC 13G/A VERTEX PHARMACEUTICALS Filed by: Capital World Investors
February 9, 2024 6:19 PM - SEC Filing
Form SC 13G/A VERTEX PHARMACEUTICALS Filed by: FMR LLC
February 9, 2024 10:08 AM - SEC Filing
Form 4 VERTEX PHARMACEUTICALS For: Feb 06 Filed by: WAGNER CHARLES F JR
February 8, 2024 4:48 PM - SEC Filing
Form 4 VERTEX PHARMACEUTICALS For: Feb 06 Filed by: Tatsis Ourania
February 8, 2024 4:46 PM - SEC Filing
Form 4 VERTEX PHARMACEUTICALS For: Feb 06 Filed by: Sachdev Amit
February 8, 2024 4:43 PM - SEC Filing
Form 4 VERTEX PHARMACEUTICALS For: Feb 06 Filed by: LEIDEN JEFFREY M
February 8, 2024 4:41 PM - SEC Filing
Form 4 VERTEX PHARMACEUTICALS For: Feb 06 Filed by: Kewalramani Reshma
February 8, 2024 4:38 PM - SEC Filing
Form 4 VERTEX PHARMACEUTICALS For: Feb 06 Filed by: Bozic Carmen
February 8, 2024 4:33 PM - SEC Filing
Form 4 VERTEX PHARMACEUTICALS For: Feb 06 Filed by: Biller Jonathan
February 8, 2024 4:29 PM - SEC Filing
Form 4 VERTEX PHARMACEUTICALS For: Feb 06 Filed by: Atkinson Edward Morrow III
February 8, 2024 4:25 PM - SEC Filing
Form 4 VERTEX PHARMACEUTICALS For: Feb 06 Filed by: Arbuckle Stuart A
February 8, 2024 4:23 PM - SEC Filing
Form 4 VERTEX PHARMACEUTICALS For: Feb 06 Filed by: Ambrose Kristen
February 8, 2024 4:21 PM - SEC Filing
Form 4 VERTEX PHARMACEUTICALS For: Feb 06 Filed by: ALTSHULER DAVID
February 8, 2024 4:10 PM - SEC Filing
Vertex (VRTX) PT Lowered to $371 at Canaccord Genuity
February 7, 2024 8:14 AM - StreetInsider
Vortex Energy Corp. Provides Update on Drilling at the Robinsons River Salt Project
February 7, 2024 8:00 AM - Globe NewsWire
Vertex (VRTX) PT Lowered to $498 at UBS
February 6, 2024 8:19 AM - StreetInsider
Vertex (VRTX) PT Raised to $450 at JPMorgan
February 6, 2024 8:15 AM - StreetInsider
Vertex (VRTX) PT Raised to $420 at RBC Capital
February 6, 2024 7:05 AM - StreetInsider
Evercore ISI Downgrades Vertex (VRTX) to In Line Citing Valuation
February 6, 2024 6:21 AM - StreetInsider
Vertex (VRTX) PT Raised to $457 at H.C. Wainwright
February 6, 2024 6:04 AM - StreetInsider
Vertex (VRTX) PT Raised to $550 at BofA Securities
February 6, 2024 5:22 AM - StreetInsider
Vertex (VRTX) PT Raised to $440 at Jefferies
February 6, 2024 3:44 AM - StreetInsider
Vertex (VRTX) PT Raised to $472 at Barclays
February 6, 2024 3:18 AM - StreetInsider
Vertex Pharma (VRTX) Tops Q4 EPS by 13c, offers guidance
February 5, 2024 4:10 PM - StreetInsider
Form 8-K VERTEX PHARMACEUTICALS For: Feb 05
February 5, 2024 4:10 PM - SEC Filing
Vertex Reports Fourth Quarter and Full Year 2023 Financial Results
February 5, 2024 4:06 PM - BizWire
Vertex Pharma (VRTX) Reports Positive Results From Trials of Vanzacaftor/Tezacaftor/Deutivacaftor
February 5, 2024 4:01 PM - StreetInsider
Vertex Announces Positive Results From Pivotal Trials of Vanzacaftor/Tezacaftor/Deutivacaftor, Next-In-Class Triple Combination Treatment for Cystic Fibrosis
February 5, 2024 4:01 PM - BizWire
Bernstein Downgrades Vertex (VRTX) to Market Perform Citing Full Valuation
February 2, 2024 4:44 AM - StreetInsider
Vertex (VRTX) PT Raised to $438 at JPMorgan
February 1, 2024 7:34 AM - StreetInsider
Vortex Energy Announces Further Extension of Marketing Campaign
January 31, 2024 5:00 PM - Globe NewsWire
Vertex (VRTX) PT Lowered to $378 at Canaccord Genuity
January 31, 2024 8:11 AM - StreetInsider
Vertex (VRTX) PT Raised to $500 at Oppenheimer
January 31, 2024 7:39 AM - StreetInsider
Maxim Group Downgrades Vertex (VRTX) to Hold
January 31, 2024 7:38 AM - StreetInsider
Vertex (VRTX) PT Raised to $508 at Truist Securities
January 31, 2024 7:24 AM - StreetInsider
Vertex (VRTX) PT Raised to $559 at Goldman Sachs
January 31, 2024 6:11 AM - StreetInsider
Baird Downgrades Vertex (VRTX) to Neutral
January 31, 2024 2:37 AM - StreetInsider
Vertex non-opioid painkiller meets main goal in late-stage trials
January 30, 2024 9:21 AM - StreetInsider
Vertex Pharma (VRTX) Reports Positive Results From the VX-548 Phase 3 Program
January 30, 2024 6:28 AM - StreetInsider
Vertex Announces Positive Results From the VX-548 Phase 3 Program for the Treatment of Moderate-to-Severe Acute Pain
January 30, 2024 6:28 AM - BizWire
Vertex (VRTX) PT Raised to $450 at Oppenheimer
January 26, 2024 6:26 AM - StreetInsider
Form SC 13G VERTEX PHARMACEUTICALS Filed by: BlackRock Inc.
January 25, 2024 1:49 PM - SEC Filing
Full Article List
